Drug Shortage Report for CEFTRIAXONE FOR INJECTION
| Report ID | 143328 |
| Drug Identification Number | 02409968 |
| Brand name | CEFTRIAXONE FOR INJECTION |
| Common or Proper name | CefTRIAXone for Injection 100 g SmartPak® |
| Company Name | FRESENIUS KABI CANADA LTD |
| Market Status | MARKETED |
| Active Ingredient(s) | CEFTRIAXONE |
| Strength(s) | 100G |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | SmartPak |
| ATC code | J01DD |
| ATC description | OTHER BETA-LACTAM ANTIBACTERIALS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2021-11-01 |
| Actual start date | 2021-11-01 |
| Estimated end date | 2021-12-21 |
| Actual end date | 2021-12-21 |
| Shortage status | Resolved |
| Updated date | 2021-12-30 |
| Company comments | Fresenius Kabi Canada regrets to advise that due to further production delays we will be extending the backorder on our CefTRIAXone for Injection 100 g SmartPak®. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2021-07-30 | English | Compare |
| v2 | 2021-07-30 | French | Compare |
| v3 | 2021-08-02 | English | Compare |
| v4 | 2021-08-31 | English | Compare |
| v5 | 2021-08-31 | French | Compare |
| v6 | 2021-10-27 | English | Compare |
| v7 | 2021-10-27 | French | Compare |
| v8 | 2021-10-27 | English | Compare |
| v9 | 2021-10-27 | French | Compare |
| v10 | 2021-11-02 | English | Compare |
| v11 | 2021-11-24 | English | Compare |
| v12 | 2021-11-24 | French | Compare |
| v13 | 2021-12-17 | English | Compare |
| v14 | 2021-12-17 | French | Compare |
| v15 | 2021-12-30 | English | Compare |
| v16 | 2021-12-30 | French | Compare |
Showing 1 to 16 of 16